Skip to main content
. 2023 Oct 17;5(5):570–590. doi: 10.1016/j.jaccao.2023.09.002

Figure 4.

Figure 4

Proposed Algorithm for Risk Stratifying and Managing Ibrutinib-Associated Arrhythmias

Among patients with suspected ibrutinib-associated cardiotoxicity, the presence of late gadolinium enhancement (LGE) or elevated native T1 is associated with a higher risk of future or recurrent cardiotoxic events. ∗Additional cardiac data on the safety of newer Bruton’s tyrosine kinase (BTK) inhibitors is still needed. CMR = cardiac magnetic resonance; ECG = electrocardiogram.